Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
REGENXBIO Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security | Security Class | Fee | Amount | Proposed | Maximum | Fee Rate | Amount of | Carry | Carry | Carry | Filing Fee | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to be Paid | Equity | Common Stock, par value $0.0001 per share | Rule 457(o) and 457(r) (1) | N/A | N/A | $150,000,000 | 0.00011020 | $16,530 | ||||||||||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||
Total Offering Amounts | $150,000,000 | $16,530 | ||||||||||||||||||||||
Total Fees Previously Paid | N/A | |||||||||||||||||||||||
Total Fee Offsets | N/A | |||||||||||||||||||||||
Net Fee Due | $16,530 |
(1) | The filing fee is calculated and is being paid pursuant to Rules 456(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price. The registrant initially deferred payment of the registration fees for its Registration Statement on Form S-3 (File No. 333-269086) filed by the Registrant with the Securities and Exchange Commission on December 30, 2022 pursuant to Rules 456(b) and 457(r) under the Securities Act. |